Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213766 Anticancer Compounds from Vernonia Guineensis
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/23/2012US20120213736 Parvovirus methods and compositions for killing neoplastic cells
08/23/2012US20120213735 Therapeutic furopyrimidines and thienopyrimidines
08/23/2012US20120213734 Method for Cancer Therapy Based on a Co-Administration of a Parvovirus and a Cytokine
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213707 Riboflavin Based Aerosol and Use as Placebo in Trials
08/23/2012US20120213705 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012US20120213701 Methods for tumor diagnosis and therapy
08/23/2012US20120213698 Loading technique for preparing radionuclide containing nanoparticles
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012CA2827673A1 Mtor/jak inhibitor combination therapy
08/23/2012CA2827645A1 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications
08/23/2012CA2827398A1 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
08/23/2012CA2827172A1 Selective fak inhibitors
08/23/2012CA2827171A1 Fak inhibitors
08/23/2012CA2825919A1 Methods of preparation of conjugates
08/23/2012CA2825243A1 Antibody against the csf-1r
08/23/2012CA2823721A1 Compositions, devices and methods of use thereof for the treatment of cancers
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489661A1 Impurity of lapatinib and salts thereof
08/22/2012EP2489371A1 Carrier peptides for drug delivery
08/22/2012EP2489366A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments
08/22/2012EP2489351A1 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treament of cancer thereof
08/22/2012EP2488640A1 Antiproliferative agent
08/22/2012EP2488553A1 Cancer treatment
08/22/2012EP2488552A1 Use of il-17 receptor a antigen binding proteins
08/22/2012EP2488533A1 Imidazothiazole-chalcone derivatives as potential anticancer agents and process for the preparation thereof
08/22/2012EP2488519A1 Pyrazolopyridine derivatives as anticancer agent
08/22/2012EP2488507A2 Novel mek inhibitors, useful in the treatment of diseases
08/22/2012EP2488504A1 Sulfoxide derivatives for treating tumors
08/22/2012EP2488491A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
08/22/2012EP2488256A1 Na-k pump modulation
08/22/2012EP2488207A2 Polymeric systems for the delivery of anticancer agents
08/22/2012EP2488204A1 Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent
08/22/2012EP2488199A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
08/22/2012EP2488186A1 Anti-neoplastic uses of artemin antagonists
08/22/2012EP2488184A1 Combination
08/22/2012EP2488183A2 Composition for inhibiting tgf- comprising imidazopurine derivatives
08/22/2012EP2488182A1 Treating neurotoxicity associated with combinations of 5 - fu or its prodrugs and dpd inhibitors
08/22/2012EP2488172A2 Dendrimer compositions and methods of synthesis
08/22/2012EP2488164A2 Release of agents from cells
08/22/2012EP2488027A1 Thiazolidinedione energy restriction-mimetic agents
08/22/2012EP2193118B1 Piperidine and piperazine derivatives for treating tumours
08/22/2012EP2155758B1 Tetrahydrofuro[3,4-d]dioxolane compounds for use in the treatment of viral infections and cancer
08/22/2012EP2007386B1 Camptothecin-analog with a novel, flipped lactone-stable, e-ring and methods for making and using same
08/22/2012EP1768679B1 Modulation of gsk-3beta and method of treating proliferative disorders
08/22/2012EP1611112B1 Isoxazole compounds as inhibitors of heat shock proteins
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012EP1503777B1 7-Hydroxy chromones as potent antioxidants
08/22/2012EP1487426B1 Methods of inducing terminal differentiation
08/22/2012CN202387005U Special polygonatum pressure steaming device
08/22/2012CN1865281B Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
08/22/2012CN1767839B Antiallergic composition
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648210A DLL4-binding molecules
08/22/2012CN102648197A Method of promoting apoptosis and inhibiting metastasis
08/22/2012CN102648194A Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
08/22/2012CN102648188A Heterocyclic sulfonamide derivatives
08/22/2012CN102648183A Substituted pyrazoles as estrogen receptor ligands
08/22/2012CN102648178A Quinazoline derivatives
08/22/2012CN102648004A Photosensitizing compositions
08/22/2012CN102647986A Method of treating proliferative disorders and other pathological conditions mediated by BCR-ABL, C-KIT, DDR1, DDR2 or PDGF-R kinase activity
08/22/2012CN102647985A Methods of using c-Met modulators
08/22/2012CN102643858A Efficiently-replicated human hepatitis B virus recombinant vector and application thereof
08/22/2012CN102643854A Eukaryon recombinant plasmid, preparation process and applications thereof
08/22/2012CN102643819A ShRNA of Rab23 and ientiviral vector and applications thereof
08/22/2012CN102643814A Antisense oligonucleotide for human miR-431 and application thereof
08/22/2012CN102643813A Human miR-504 antisense oligonucleotide and application thereof
08/22/2012CN102643812A Human miR-1227 antisense oligonucleotide and application thereof
08/22/2012CN102643811A Human miR-1229 antisense oligonucleotide and application thereof
08/22/2012CN102643810A Human miR-299-5p antisense oligonucleotide and application thereof
08/22/2012CN102643809A Antisense oligodeoxyncleotide of human miR-1274b and application thereof
08/22/2012CN102643808A Antisense oligodeoxyncleotide of human miR-1539 and application thereof
08/22/2012CN102643807A Antisense oligodeoxyncleotide of human miR-484 and application thereof
08/22/2012CN102643806A Antisense oligodeoxyncleotide of human miR-1913 and application thereof
08/22/2012CN102643785A Method for targeted inhibition of infiltration and transfer of glioma cells and application of method
08/22/2012CN102643783A Preparation method of activated mononuclear cell for cell immunotherapy
08/22/2012CN102643765A Streptomyces, anti-tumor compound (Spiro-Indimycin A-D) as well as preparation method and application thereof
08/22/2012CN102643361A Nano selenium micromolecular microbial polysaccharide as well as preparation method and application thereof
08/22/2012CN102643345A Bispecific anti-egfr/anti-igf-1r antibodies
08/22/2012CN102643344A Binding constructs and methods for use thereof
08/22/2012CN102643333A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
08/22/2012CN102643330A Synthetic method for aspartate hexapeptide danshensu as bone targeted drug and medical application of aspartate hexapeptide danshensu
08/22/2012CN102643326A 3,6-dihydroxyl-22(27)imino-4-furan sterene and preparation method and application thereof
08/22/2012CN102643308A Oxaliplatin crystal compound and freeze-dried powder injection
08/22/2012CN102643280A Folic-acid-modified phthalocyanino-silicon, and preparation method and application thereof
08/22/2012CN102643278A Pyrrolo[2,3-d]pyrimidine derivative and application in preparation of anti-malignant tumor medicament thereof
08/22/2012CN102643272A Novel thieno [3, 2-d] pyrimidine compound
08/22/2012CN102643268A 喹啉类及噌啉类化合物及其应用 Quinoline compounds and cinnolinyl class and its application
08/22/2012CN102643252A Piperazinoacethydrazide-containing diarylurea derivatives and application thereof
08/22/2012CN102643247A Disulfide compound as well as preparation method and application thereof
08/22/2012CN102643233A Analogs of benzoquinone-containing ansamycins for the treatment of cancer
08/22/2012CN102643230A 7-site substituted quinolone compound and application thereof in preparation of anti-tumor medicaments
08/22/2012CN102643229A N-((4-chloro-3-trifluoromethyl) phenyl)-N'-((2-fluoro-4-(2-formamyl)-4-pyridyloxy) phenyl) urea and application thereof serving as anticancer medicament
08/22/2012CN102643225A Ionic liquid, nano fluorescent ellipsoid and preparation method thereof
08/22/2012CN102643214A Preparation method and preparation of vorinostat I crystal form large grains
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 2211